Results 131 to 140 of about 368,229 (351)

LP-203 The new markers of systemic lupus erythematosus activity: focus on interleukin (IL)-1b and soluble IL-2 receptor

Lupus Science and Medicine, 2023
Mariia Aristova, Tatyana Panafidina, Yulia Gorbunova, Anastasiya Avdeeva, Tatyana Popkova   +4 more
doaj   +1 more source

A Case of Tumid Lupus Erythematosus Successfully Treated with Topical Tacrolimus and Hydrocortisone 17-Butyrate

Gazi Medical Journal
Tumid lupus erythematosus is an uncommon subtype of chronic cutaneous lupus erythematosus. Hereby, we report a 36-year-old male patient with tumid lupus erythematosus who presented with erythematous papules and plaques on the face and neck who showed ...
Funda Tamer, İrem Özdemir, Betül Öğüt, Özlem Erdem   +3 more
doaj   +1 more source

A comprehensive exploration of the heterogeneity of immune cells in Han and Zang systemic lupus erythematosus patients via single-cell RNA sequencing

, 2023
Yongzhuo Wu, Chongjun Weng, Yali Zhou, Qinghuan Zhu, Yingying Liu, Zheng Jun-Juan, Binbin Yang, Wenting Cao, Limei Yuan, Meng Yang, Danqi Deng   +10 more
openalex   +1 more source

Comparative Safety Profiles of Ocrelizumab and Rituximab in Multiple Sclerosis Treatment Using Real‐World Evidence

Annals of Neurology, EarlyView.
Objective The objective of this study was to compare the long‐term safety profiles of ocrelizumab and rituximab in persons with multiple sclerosis (MS). Methods Using retrospective data from the University of California (UC) Health System, we simulated a target clinical trial. The primary cohort from UC San Francisco (UCSF) and a validation cohort from
Gabriel Cerono, Bruce A.C. Cree, Stephen L. Hauser, Sergio E. Baranzini   +3 more
wiley   +1 more source

LP-048 Characteristics and clinical outcome of incomplete systemic lupus erythematosus

Lupus Science and Medicine, 2023
Anastasiia Shumilova, Evgeniy Nasonov, Yulia Gorbunova, Tatiana Popkova, Tatiana Panafidina, Liubov Kondrateva, Alexandr Lila   +6 more
doaj   +1 more source

Recurrent podocytopathy in a patient with systemic lupus erythematosus

SAGE Open Medical Case Reports, 2017
Podocytopathy in systemic lupus erythematosus is characterised by diffuse foot process effacement without significant peripheral capillary wall immune deposits as seen on electron microscopy.
Shereen Paramalingam, Daniel D Wong, Gursharan K Dogra, Johannes C Nossent   +3 more
doaj   +1 more source

LP-027 Overweight and obesity phenotypes based on body mass index and insulin resistance in women with systemic lupus erythematosus

Lupus Science and Medicine, 2023
Yulia Gorbunova, Elena Gerasimova, Tatiana Popkova, Tatiana Panafidina, Liubov Kondrateva   +4 more
doaj   +1 more source

For the eye altering, alters the all [PDF]

, 2015
C
Boey, Olivier, Bogaert, Anne-Marie, De Scheerder, Marie-Angélique, Mahieu, Elien, Vanuytsel, Johan   +4 more
core   +1 more source

LP-026 Obesity, hyperleptinemia and insulin resistance in women with systemic lupus erythematosus and rheumatoid arthritis

Lupus Science and Medicine, 2023
Yulia Gorbunova, Elena Gerasimova, Tatiana Popkova, Tatiana Panafidina, Liubov Kondrateva   +4 more
doaj   +1 more source

Drug-induced lupus erythematosus associated with donepezil: a case report [PDF]

, 2015
Ciro Manzo, Salvatore Putignano
openalex   +1 more source